I Hellström

1.8k total citations
37 papers, 1.4k citations indexed

About

I Hellström is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, I Hellström has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 12 papers in Molecular Biology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in I Hellström's work include Immunotherapy and Immune Responses (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Virus-based gene therapy research (6 papers). I Hellström is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Virus-based gene therapy research (6 papers). I Hellström collaborates with scholars based in United States, South Africa and Sweden. I Hellström's co-authors include K E Hellström, K. E. Hellström, George E. Pierce, Alexander H. Bill, H. Jacques Garrigues, Ursula Garrigues, Joseph P. Brown, M Y Yeh, Edward Nudelman and Steven B. Levery and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

I Hellström

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Hellström United States 18 671 656 585 418 109 37 1.4k
R A Reisfeld United States 18 480 0.7× 629 1.0× 805 1.4× 315 0.8× 246 2.3× 28 1.3k
Z Steplewski United States 17 502 0.7× 654 1.0× 678 1.2× 444 1.1× 27 0.2× 30 1.3k
Thomas J. McKearn United States 17 849 1.3× 758 1.2× 530 0.9× 293 0.7× 17 0.2× 36 1.8k
J M Pesando United States 13 812 1.2× 453 0.7× 379 0.6× 242 0.6× 35 0.3× 16 1.4k
Peisheng Hu United States 29 986 1.5× 697 1.1× 722 1.2× 812 1.9× 60 0.6× 62 2.0k
Randy Robinson United States 13 479 0.7× 773 1.2× 767 1.3× 368 0.9× 148 1.4× 31 1.5k
Ezogelin Oflazoglu United States 18 703 1.0× 727 1.1× 463 0.8× 809 1.9× 51 0.5× 23 1.7k
Ulrich Brinck Germany 23 303 0.5× 239 0.4× 812 1.4× 478 1.1× 38 0.3× 98 1.6k
Josef Mysliwietz Germany 18 478 0.7× 199 0.3× 636 1.1× 540 1.3× 25 0.2× 47 1.7k
S Carrel Switzerland 16 369 0.5× 339 0.5× 318 0.5× 179 0.4× 38 0.3× 27 787

Countries citing papers authored by I Hellström

Since Specialization
Citations

This map shows the geographic impact of I Hellström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Hellström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Hellström more than expected).

Fields of papers citing papers by I Hellström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Hellström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Hellström. The network helps show where I Hellström may publish in the future.

Co-authorship network of co-authors of I Hellström

This figure shows the co-authorship network connecting the top 25 collaborators of I Hellström. A scholar is included among the top collaborators of I Hellström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Hellström. I Hellström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huse, William D., Scott Glaser, Lisa Starr, et al.. (1992). Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening, and mutagenesis of F(ab) antibody fragments. The Journal of Immunology. 149(12). 3914–3920. 36 indexed citations
2.
Hellström, I, H. Jacques Garrigues, Ursula Garrigues, & K E Hellström. (1990). Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens.. PubMed. 50(7). 2183–90. 204 indexed citations
3.
Neuwelt, Edward A., H H Van Tol, Y. Peng Loh, et al.. (1990). Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma.. Proceedings of the National Academy of Sciences. 87(24). 9928–9932. 25 indexed citations
4.
Robinson, Randy, et al.. (1987). Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity.. The Journal of Immunology. 139(10). 3521–3526. 122 indexed citations
5.
Nudelman, Edward, Sen‐itiroh Hakomori, Reiji Kannagi, et al.. (1982). Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2.. Journal of Biological Chemistry. 257(21). 12752–12756. 183 indexed citations
6.
Hellström, I, Joseph P. Brown, & K E Hellström. (1981). Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in complement-dependent cytotoxicity.. The Journal of Immunology. 127(1). 157–160. 39 indexed citations
7.
Brown, Jabari, et al.. (1980). Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.. The Journal of Immunology. 124(6). 2552–2556. 6 indexed citations
8.
Nelson, Karen, et al.. (1980). T-T hybridoma product specifically suppresses tumor immunity.. Proceedings of the National Academy of Sciences. 77(5). 2866–2870. 14 indexed citations
9.
Spence, Alex M., K E Hellström, I Hellström, et al.. (1979). Immunization against ethylnitrosourea-induced autochthonous neurogenic rat tumours. British Journal of Cancer. 40(1). 164–167. 2 indexed citations
10.
Riley, Riley, D. Spackman, Kjell Hellström, & I Hellström. (1978). Growth enhancement of murine sarcoma by ldh-virus, adreno- corticoids, and anxiety stress. Abstr.. 57. 1 indexed citations
11.
Nepom, Gerald T., I Hellström, & K. E. Hellström. (1977). Antigen-specific purification of blocking factors from sera of mice with chemically induced tumors.. Proceedings of the National Academy of Sciences. 74(10). 4605–4609. 21 indexed citations
12.
Hellström, I, et al.. (1976). Spontaneous tumor regression: possible relationship to in vitro parameters of tumor immunity.. PubMed. 44. 131–4. 5 indexed citations
13.
Wright, P., Roseanna Hargreaves, Irwin D. Bernstein, & I Hellström. (1974). Fractionation of Sera from Operationally Tolerant Rats by DEAE Cellulose Chromatography; Evidence that Serum Blocking Factors Are Associated with IgG. The Journal of Immunology. 112(3). 1267–1270. 5 indexed citations
14.
Hellström, I, et al.. (1974). Lymphocyte mediated cytotoxicity to tumor antigens.. PubMed. 3. 37–50. 3 indexed citations
15.
Bansal, S. C., K E Hellström, I Hellström, & Hans Sjögren. (1973). CELL-MEDIATED IMMUNITY AND BLOCKING SERUM ACTIVITY TO TOLERATED ALLOGRAFTS IN RATS. The Journal of Experimental Medicine. 137(3). 590–602. 18 indexed citations
16.
Hellström, I, et al.. (1973). Some recent studies on cellular immunity to human melanomas.. PubMed. 32(2). 156–9. 43 indexed citations
17.
Chapman, Warren H., et al.. (1972). Immunological Studies on Urinary Bladder Tumors of Rats and Mice. Science. 176(4041). 1337–1340. 69 indexed citations
18.
Hellström, I, et al.. (1971). Cellular immunity and blocking antibodies to tumors.. PubMed. 10(1). 131–6. 10 indexed citations
19.
Hellström, I, K E Hellström, George E. Pierce, & Alexander H. Bill. (1968). Demonstration of cell-bound and humoral immunity against neuroblastoma cells.. Proceedings of the National Academy of Sciences. 60(4). 1231–1238. 249 indexed citations
20.
Hellström, K. E. & I Hellström. (1965). Syngeneic preference and allogeneic inhibition.. PubMed. 3. 79–93. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026